2014 Neurotech Leaders Forum

8:00-8:30

Registration and Coffee

8:30-9:15

State of the Neurotechnology Industry: 2014

James Cavuoto, Editor and Publisher, Neurotech Reports

Neurotech Business Report Editor James Cavuoto provides his insights and observations on the last decade in the neurotechnology industry. He surveys changes in the competitive landscape that have occured over the years, the most significant events of the last decade, and challenges confronting the industry in years ahead.

9:15-10:00

Keynote Address

Mir Imran, Chairman and CEO, InCube Labs

10:00-10:30

Refreshment Break, Sponsored by Micro Systems Technologies

10:30-11:15

Neurotech Funding Opportunities

James Cavuoto, Editor, Neurotech Reports, Moderator

Kip Ludwig, Ph.D., Program Director, Neural Engineering, National Institutes of Health

In this session, a panel of entrepreneurs, investors, and funding agency representatives offer their perspective on the outlook for funding neurotech startup firms. We'll look at examples pf recent public and private financings and explore opportunities for nondilutive financing.

11:15-12:00

Advances in Neural Interfaces

Victor Pikov, Ph.D., Senior Scientist, Huntington Medical Research Institutes, Moderator

In this session, we'll take a look at recent technology advances in neurotechnology and examine their potential impact on the market. We'll explore new developments in electrode materials, lead design, interconnects, and stimulation paradigms.

12:00-1:30

Luncheon, Sponsored by Cirtec Medical

Presentation of 2014 Gold Electrode Awards

1:30-3:00

Neurotechnology Entrepreneur Panel

James Cavuoto, Editor, Neurotech Reports, Moderator

This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm's technology and markets.

3:00-3:30

Refreshment Break, Sponsored by Micro Systems Technologies

3:30-4:15

Bionic Pioneers: Advances in Neuroprosthetics

Jennifer French, Executive Director, Neurotech Network, Moderator

In this session, we'll look at the market for both sensory and motor neuroprosthetics, discussing advances in devices such as cochlear implants, retinal implants, functional electrical stimulation, robotic exoskeletons. We'll look at both established and emerging competitors in this market and examine the outlook for market expansion.

4:15-5:00

Partners in Research: Neuroscience Meets Neuroenginnering

James Cavuoto, Editor, Neurotech Reports, Moderator

Kewal Jain, M.D., President, Jain PharmaBiotech

In this session, we'll examine the vital interplay between basic neuroscience research and advances in neuroengineering applications like deep brain stimulation and spinal cord stimulation. How have early DBS depression studies expanded our understanding of the neural circuits involved with depression? How have innovations in SCS therapy enhanced our knowledge of how pain is transmitted in the CNS?.

5:00-7:00

Cocktail Reception, Sponsored by Stellar Technologies

8:00:8:30

Registration and Coffee

8:30-9:15

The Consumer Market for Neurotechnology

James Cavuoto, Editor and Publisher, Neurotech Reports

9:15-10:00

Cortical Stimulation Systems

James Cavuoto, Editor and Publisher, Neurotech Reports, Moderator

In this session, we look at new technology emerging from the U.S., Europe, and Asia for treating neurological disorders using transcranial magnetic and electrical stimulation. We'll examine the different stimulation paradigms in use and explore the market potential for each.

10:00-10:30

Coffee Break, Sponsored by Micro Systems Technologies

10:30-11:15

Decoding User Intent

Jose Contreras-Vidal, Ph.D., Director, Laboratory for Noninvasive Brain-Machine Interface Systems, University of Houston

Chad Bouton, R&D Leader, Neurotechnology and Molecular Imaging, Battelle

Both consumer and medical neurotech applications often require the system to decode user intent via a brain-computer interface, peripheral nerve sensor, or other technology. In this session, we'll look at advances in neurosensing technology that stand to benefit neurotechnology users.

11:15-12:00

Fast-tracking Neurotech Investment

James Cavuoto, Editor and Publisher, Neurotech Reports, Moderator

Manuel Lopez-Figueroa, Ph.D., Vice President, Bay City Capital

Robert Abrams, Ph.D., Operating Partner, Sanderling Ventures

Noninvasive neurotech devices often have a faster route to market than implanted systems because of streamlined regulatory approval and less reliance on reimbursement decisions. In this session we'll examine the outlook for venture capital investment in noninvasive and consumer neurotech startups.

12:00-1:30

Luncheon, Sponsored by Cirtec Medical

1:30-3:00

Neurotechnology Entrepreneur Panel

James Cavuoto, Editor, Neurotech Reports, Moderator

Shai Gozani, M.D., Ph.D., President and CEO, NeuroMetrix, Inc.

This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm's technology and markets.

3:00-3:30

Refreshment Break, Sponsored by Micro Systems Technologies

3:30-4:15

Neurotech Games for Fun and Therapy

James Cavuoto, Editor and Publisher, Neurotech Reports, Moderator

Chris Berka, President and CEO, Advanced Brain Monitoring

Amy Kruse, Ph.D., Vice-President, Innovation, Intific Inc.

The consumer market for neurotech offers an array of new games that can be used for therapeutic or entertainmanet applications. In this session, we'll look at some of the offerings in both categories and explore future orrortunities in this segment.

4:15-5:00

The Era of the Brain

Jennifer French, Executive Director, Neurotech Network, Moderator

Evian Gordon, Ph.D., Chariman and CEO, Brain Resource Ltd.

Advances in our understanding of the brain and development of new neurotech tools has placed enormous responsibilities on researchers, clinicians, manufacturers, and regulators. In this session, we'll look at the potential future implications of programs like the president's BRAIN initiative and its impact on people with neurological and psychiatric disorders.

5:00-7:00

Cocktail Reception, Sponsored by Stellar Technologies